Cytokine profile of nasal polyps and clinical characteristics of patients with polypous rhinosinisitis at different degree of therapeutic control and disease severity

The issues of recurrencies in chronic rhinosinusitis with nasal polyps (CRSwNP) still remain unresolved. Therefore, detection patients with uncontrolled clinical course of CRSwNP is required.

The aim of the present study was to assess cytokine profile in nasal polyps as well as clinical characteristics of patients with CRSwNP at varying levels of therapeutic control.

The study included 99 patients with chronic rhinosinusitis. The contents of interferon IFNγ, interleukin IL- 1β, IL-4, IL-5, IL-13, tumor necrosis factor TNFα, transforming growth factors TGF-β1, TGF-β2, TGF-β3 were measured in polyp tissue samples by means of multiplex analysis. The patients were treated according to a stepwise СRSwNP therapeutic algorithm [9]. Following observation for 5 years, all patients were divided into groups, as based on medical control degree. Group 1 included patients with mild CRSwNP, who mainly received stage I and II treatment for the entire observation period. Group 2 was presented by moderate- severity CRSwNP, with stage II or III therapy according to the referred algorithm. Group 3 included the patients with severe CRSwNP who received one or more stage IV courses. The patients underwent repeated SNOT-22 questionnaire, endoscopic examination, clinical assessment. In case of bronchial asthma (BA), ACQ-7 was repeated. Initial cytokine profile of nasal polyps was analyzed by the mentioned clinical groups.

Results:

1. After 5 years of observations in group 1 (mild CRSwNP), we found a minimal decrease in quality of life (SNOT-22), severity of nasal congestion, or smell impairment. Bronchial asthma duration in these patients was significantly lower compared to group 3, the patients had better asthma control level. Cytokine profile of nasal polyps was characterized by the highest IL-4 concentration, average values IL-1β, TNFα, IFNγ and minimal TGF-β1 values.
2. In group 2 (moderate CRSwNP), we noted more pronouced impairment of smell, nasal congestion and quality of life. Bronchial asthma was less controlled than in group 1. The maximal concentrations of IFNγ, IL-1β, TNFα, IL-5, TGF-β1, TGF-β2 were registered.
3. In group 3 with poor CRSwNP control, the highest SNOT-22 scores, severity of difficulty in nasal breathing, impaired sense of smell were revealed. Duration of bronchial asthma was longer, with lowest levels of medical control. In nasal polyps, minimal levels of IFNγ, IL-1β, TNFα, IL-4, IL-5, TGF-β2, TGF-β3 were noted.
4. Treatment of patients depending on the clinical phenotypes of CRSwNP in the presence/absence of allergic rhinitis or bronchial asthma may improve control and reduce incidence of relapses in CRSwNP.

1. Aschina L.A., Baranova N.I., Molotilov B.A., Shkurova N.A. Analysis of neutrophil functional activity in patients with chronic polyposis rhinosinusitis after treatment with interferon gamma. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics, 2022, Vol. 67, no. 6, pp. 339-344. (In Russ.)

2. Zurochka A.V., Semenov M.V., Zurochka V.A., Hajdukov, S.V. Study of immune system parameters and T-regulatory cell levels in patients suffering from polypous rhinosinusitis. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2011, Vol. 5, no. 14, pp. 280-285. (In Russ.)

3. Korkmazov M.Y., Kazachkov E.L., Lengina M.A., Dubinets I.D., Korkmazov A.M. Cause-effect factors of rhinosinusitis poliposa development. Rossiyskaya rinologiya = Russian Rhinology, 2023, Vol. 31, no. 2, pp. 124-130. (In Russ.)

4. Korkmazov M.Yu., Lengina M.A., Dubinets I.D., Kravchenko A.Yu., Klepikov S.V. Some immunological aspects of targeted therapy in polypous rhinosinusitis. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2023, Vol. 26, no. 3, pp. 301-306. (In Russ.) doi: 10.46235/1028-7221-8955-SIA.

5. Korkmazov M.Yu., Lengina M.A., Korkmazov A.M., Kravchenko A.Yu. Effect of post-COVID syndrome on the quality of life of patients with allergic rhinitis and eosinophilic phenotype of chronic polyposis rhinosinusitis. Rossiyskiy meditsinskiy zhurnal = Medical Journal of the Russian Federation, 2023, Vol. 29, no. 4, pp. 277-290. (In Russ.)

6. КKrysanov I.S., Krysanova V.S., Ermakova V.Yu. A social-economic burden of rhinosinusitis with nasal polyps with comorbid asthma and influence of dupilumab. Kachestvennaya klinicheskaya praktika = Good Clinical Practice, 2021, no. 3, pp. 16-30. (In Russ.)

7. avlush D.G., Gilifanov E.A., Tyutyunkova A.I., Olikyan V.N., Trofimova A.V., Sevostyanova I.S., Gorbach N.A., Mizanova V.Zh. Neurokinin system activity of nasal cavity mucosa in rhinosinusitis with nasal polyps. Rossiiskaya otorinolaringologiya = Russian Otorhinolaryngology, 2021, Vol. 20, no. 4, pp. 33-42. (In Russ.)

8. СSavlevich E.L., Gaganov L.V., Egorov V.I., Kurbacheva O.M., Mitrofanova E.S., Pelishenko T.G., Lyubimova E.V. Application of eosinophil-neutrophil index eni and degree of inflammatory infiltration to assess the inflammatory process in polypous rhinosinusitis. Rossiiskaya otorinolaringologiya = Russian Otorhinolaryngology, 2022, Vol. 21, no. 5, pp. 70-81. (In Russ.)

9. Savlevich E.L., Dyneva M.E., Gaganov L.E., Egorov V.I., Gerasimov A.N., Kurbacheva O.M. Diagnostic and treatment algorithm for different phenotypes of chronic rhinosinusitis with nasal polyps. Rossiyskiy allergologicheskiy zhurnal = Russian Allergology Journal, 2019, Vol. 16, no. 2, pp. 50-60. (In Russ.)

10. Savlevich E.L., Zurochka A.V., Kurbacheva O.M., Egorov V.I., Shilovskiy I.P., Mitrofanova E.S., Lyubimova E.V. Pleiomorphism of the cytokine profile in nasal polyp tissue depending on the phenotype of chronic rhinosinusitis with nasal polyps. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology, 2023, Vol. 88, no. 1, pp. 50-56. (In Russ.)

11. Savlevich E.L., Zurochka A.V., Kurbacheva O.M., Egorov V.I., Gaganov L.E., Lyubimova E.V. Transforming growth factors TGF-β1, TGF-β2 and TGF-β3 in the tissue of nasal polyps in different phenotypes of chronic rhinosinusitis with nasal polyps. Meditsinskaya immunologiya = Medical Immunology (Russia), 2022, Vol. 24, no. 1, pp. 147-156. (In Russ.) doi: 10.15789/1563-0625-TGF-2365.

12. Savlevich E.L., Kozlov V.S., Kurbacheva O.M. The modern trends in the diagnostic search for and the treatment of chronic rhinosinusitis with nasal polyps. Rossiyskaya rinologiya = Russian Rhinology, 2018, Vol. 26, no. 2, pp. 41-47. (In Russ.)

13. Svistushkin V.M., Chichkova N.V., Pshonkina D.M. Eosinophilia as a predictor of recurrent course polypoid rhinosinusitis after surgical treatment. Consilium Medicum = Consilium Medicum, 2019, Vol. 21, no. 11, pp. 34-37. (In Russ.)

14. Svistushkin V.M., Chichkova N.V., Pshonkina D.M. Periostin as a promising biological marker of early recurrence of polyposis rhinosinusitis after surgical treatment. Meditsinskiy sovet = Medical Council, 2021, no. 6, pp. 113-119. (In Russ.)

15. Semenov M.V., Zurochka A.V., Zurochka V.A. Naming the number of T-regulatory cells in patients suffering from polypous rhinosinusitis during treatment with nasal topical glucocorticosteroids. Meditsinskaya immunologiya = Medical Immunology (Russia), 2012, Vol. 14, no. 3, pp. 233-238. (In Russ.) doi: 10.15789/1563-0625-2012-3-233-238.

16. Yanov Yu.K., Egorov V.I., Savlevich E.L., Pelishenko T.G., Kirichenko I.M. Expediency of radical methods of endoscopic procedures on paranasal sinuses in chronic rhinosinusitis with nasal polyps. Rossiiskaya otorinolaringologiya = Russian Otorhinolaryngology, 2023, Vol. 22, no. 1, pp. 63-73. (In Russ.)

17. Brescia G., Zanotti C., Parrino D., Barion U., Marioni G. Nasal polyposis pathophysiology: endotype and phenotype open issues. Am. J. Otolaryngol., 2018, Vol. 39, no. 4, pp. 441-444.

18. Eweiss A., Dogheim Y., Hassab M., Tayel H., Hammad Z. VCAM-1 and eosinophilia in diffuse sino-nasal polyps. Eur. Arch. Otorhinolaryngol., 2009, Vol. 266, no. 3, pp. 377-383.

19. Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S., Toppila-Salmi S., BernalSprekelsen M., Mullol J., Alobid I., Terezinha Anselmo-Lima W., Bachert C., Baroody F., von Buchwald C., Cervin A., Cohen N., Constantinidis J., de Gabory L., Desrosiers M., Diamant Z., Douglas R.G., Gevaert P.H., Hafner A., Harvey R.J., Joos G.F., Kalogjera L., Knill A., Kocks J.H., Landis B.N., Limpens J., Lebeer S., Lourenco O., Meco C., Matricardi P.M., O’Mahony L., Philpott C.M., Ryan D., Schlosser R., Senior B., Smith T.L., Teeling T., Tomazic P.V., Wang D.Y., Wang D., Zhang L., Agius A.M., Ahlstrom-Emanuelsson C., Alabri R., Albu S., Alhabash S., Aleksic A., Aloulah M., Al-Qudah M., Alsaleh S., Baban M.A., Baudoin T., Balvers T., Battaglia P., Bedoya J.D., Beule A., Bofares K.M., Braverman I., Brozek-Madry E., Richard B., Callejas C., Carrie S., Caulley L., Chussi D., de Corso E., Coste A., El Hadi U., Elfarouk A., Eloy P.H., Farrokhi S., Felisati G., Ferrari M.D., Fishchuk R., Grayson W., Goncalves P.M., Grdinic B., Grgic V., Hamizan A.W., Heinichen J.V., Husain S., Ping T.I., Ivaska J., Jakimovska F., Jovancevic L., Kakande E., Kamel R., Karpischenko S., Kariyawasam H.H., Kawauchi H., Kjeldsen A., Klimek L., Krzeski A., Kopacheva Barsova G., Kim S.W., Lal D., Letort J.J., Lopatin A., Mahdjoubi A., Mesbahi A., Netkovski J., Nyenbue Tshipukane D., Obando-Valverde A., Okano M., Onerci M., Ong Y.K., Orlandi R., Otori N., Ouennoughy K., Ozkan M., Peric A., Plzak J., Prokopakis E., Prepageran N., Psaltis A., Pugin B., Raftopulos M., Rombaux P., Riechelmann H., Sahtout S., Sarafoleanu C.C., Searyoh K., Rhee C.S., Shi J., Shkoukani M.,

20. Shukuryan A.K., Sicak M., Smyth D., Sindvongs K., Soklic Kosak T., Stjarne P., Sutikno B., Steinsvag S., Tantilipikorn P., Thanaviratananich S., Tran T., Urbancic J., Valiulius A., Vasquez de Aparicio C., Vicheva D., Virkkula P.M., Vicente G., Voegels R., Wagenmann M.M., Wardani R.S., Welge-Lussen A., Witterick I., Wright E., Zabolotniy D., Zsolt B., Zwetsloot C.P. European position paper on rhinosinusitis and nasal polyps. Rhinology, 2020, Vol. 58. 464 p.

21. van Zele T., Holtappels G., Gevaert P., Bachert C. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps. Am. J. Rhinol. Allergy, 2014, Vol. 28, no. 3, pp. 192-198.

22. Vlaminck S., Vauterin T., Hellings P.W., Jorissen M., Acke F., van Cauwenberge P., Bachert C., Gevaert P. The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: a 3-year prospective observational study. Am. J. Rhinol. Allergy, 2014, Vol. 28, no. 3, pp. 260-264.

23. Wang G., Zheng H., Chen X., Zheng J., Zhan J., Li R., Qi Y., Ye Y., Zeng M., Wei X. Exploration of Predictive Biomarkers for Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps Based on Serum MultipleCytokine Profiling. Mediators Inflamm., 2022, Vol. 2022, 1061658. doi: 10.1155/2022/1061658.

24. Yamada T., Miyabe Y., Ueki S., Fujieda S., Tokunaga T., Sakashita M., Kato Y., Ninomiya T., Kawasaki Y., Suzuki S., Saito H. Eotaxin-3 as a plasma biomarker for mucosal eosinophil infiltration in chronic rhinosinusitis. Front. Immunol., 2019, Vol. 10, 74. doi: 10.3389/fimmu.2019.00074.

25. Zhang F., Xu Z., He X., Sun Y., Zhao C., Zhang J. Increased B cell-activating factor expression is associated with postoperative recurrence of chronic rhinosinusitis with nasal polyps. Mediators Inflamm., 2022, Vol. 2022, 7338692. doi: 10.1155/2022/7338692.